SPOTLIGHT -
May 15th 2023
Deutetrabenazine extended-release tablets are now available.
February 23rd 2023
A new, easy-to-use scale might be able to help clinicians determine the impact of tardive dyskinesia on patient functioning.
June 11th 2021
March 30th 2021
The first study to gather unsolicited patient responses via social media finds 3 negative themes.
May 30th 2019
Numbers don’t tell the whole story, but gaining a better sense of the frequency, risks, and impact on patients’ quality of life can help improve treatment efforts and enhance outcomes.